COMP <GO>
FHTX vs NBP // 10Y YIELD & FRED MACRO BETA
Foghorn Therapeutics Inc. (NASDAQ) VS. NovaBridge Biosciences (NASDAQ) • 15-METRIC TALLY: FHTX 3
— NBP 0
■ METRIC PARITY
LAST: $2.13 (0.00%) • MKT CAP: $126.5M
macro-sensitivity
—
LAST: $1.01 (-5.61%) • MKT CAP: $123.5M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FHTX VS. NBP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FHTX | NBP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 36.80% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 1/9 | +2.00 | FHTX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 33.7 | 30.1 | +3.60 | FHTX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $126.5M | $123.5M | $3.0M | FHTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FHTX REV | NBP REV | FHTX GROSS % | NBP GROSS % | FHTX FCF | NBP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $30.9M | $264.0M | — | — | -$86.1M | — |
| FY 2024 | $22.6M | $144.0M | — | — | -$101.3M | — |
| FY 2023 | $34.2M | $632.0K | — | — | -$118.1M | -$183.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FHTX // BETA —
NBP // BETA —